ATR and small cell lung carcinoma: It demonstrated that DNA replication stress as a therapeutic vulnerability of SCLC, higher neuroendocrine differentiation and enhanced RS had the more sensitivity to ATR and TOP1 inhibition, which contributed durable tumor release in platinum-resistant patients.